Bajaj HealthCare Limited (BAJAJHCARE)
₹552.05
INR-15.25(-2.69%)
As of December 26, 2024 9:59:00 AMBajaj HealthCare Limited Share Price Information
24 hour Low and High
The lowest and highest prices reached in the last 24 hours of trading
Low: ₹546.65
High: ₹568.1
All time High
The highest price the stock has ever reached since being listed
₹570.00
Price Change 1h
Price change in the last hour of trading
+₹-15.25 +-2.69%
Price Change 1d
Price change over the last trading day
+₹-15.25 +-2.69%
Price Change 1w
Price change over the last week of trading
+₹-32.75 +-5.60%
Bajaj HealthCare Limited Market Information
Exchange
The Exchange where the trading of the stock takes place
NSE
Market Cap
The current market capitalisation of the stock
₹1421.01 Cr
About Bajaj HealthCare Limited Share
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 amino 1 adamantanol, N boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.
Sector
Healthcare
Drug Manufacturers - Specialty & Generic
Employees
about
1049
CEO
NA
Revenue (2023)
NA
NA
Country of Origin
India
Key Highlights
Bajaj HealthCare Limited Resource
FAQs
The current price of Bajaj HealthCare Limited is INR 552.05 — it has changed by -2.69% in the past 24 hours. Watch Bajaj HealthCare Limited's stock price performance more closely on the chart.
Bajaj HealthCare Limited has a market capitalization of 14210100224 as of today.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bajaj HealthCare Limited's EBITDA is INR undefined
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Bajaj HealthCare Limited stocks are traded under the ticker NA
As of December 26, 2024, the company has 1049 employees.